Background. The post-cardiac arrest (CA) period is often associated with secondary damage of the brain that leads to severe neurological deficits. The current practice guidelines recommend the use of therapeutic hypothermia (TH) to prevent neurological deficit and improve survival.
Introduction
Cardiac arrest (CA) remains the major cause of sudden death; each year it affects around 375,000 people in Europe. Recovery from cardiac arrest with a delayed return of spontaneous circulation (ROSC) of more than 5 min is usually associated with an anoxic neurologic injury and is recognized as an important factor for increased morbidity and mortality. 1 Therapeutic hypothermia (TH) is a well-established method which has shown a positive impact on these outcomes. [2] [3] [4] The European Society of Cardiology strongly recommends the use of TH early after resuscitation of CA patients presenting acute myocardial infarction with ST-segment elevation (class I, evidence B) who are comatose or under deep sedation. 5 Similarly, the recent European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-Resuscitation Care 2015 recommend active cooling of patients after CA. 6 It should be underlined that TH is one of many treatment methods used along the resuscitation care chain and should not preclude implementation of other strategies. Furthermore, in order to ensure a high quality of care and safety, all teams providing TH must undergo dedicated training on the cooling protocol and TH methods.
The last survey, conducted in 2010, before European Society of Cardiology (ESC) guidelines were published, showed that the proportion of intensive care units (ICU) using TH in Poland was only 21.7%. 7 The ICUs are usually managed by anesthesiologists, whereas patients after CA are often admitted to the cardiac intensive care units (CICU) and treated by cardiologists, therefore it is important to assure that access to TH management is also available in these units. At present, it is unknown what percentages of cardiology centers have a dedicated TH program in place and are able to offer it to their patients in everyday practice. To investigate this matter, and to identify the main barriers for the implementation of a TH program, we have conducted a survey among cardiology centers that treat patients after CA.
TH, defined as controlled cooling of patients after cardiac arrest to a temperature between 32 and 34°C for a period of at least 24 h, aims to temper the post-cardiac arrest syndrome inflammatory cascade. One of the underlining mechanisms that provide beneficial effects is the reduction of release of excitatory amino acids and free radicals, which terminate activating programmed cell death pathways. Moreover, the intracellular consequences of excitotoxin exposure are minimized. Furthermore, hypothermia influences cerebral blood volume, cerebral metabolic rate of oxygen and intracranial pressure, which are all decreased. As a consequence, oxygen demand and the function of the brain might be improved. 1 In recent years, the development of TH programs across Poland has been actively supported by the Polish Cardiac Society, which, among others, included the foundation of the Polish National Registry of Therapeutic Hypothermia. In January 2014, the National Health Fund announced a dedicated reimbursement code for TH that ultimately eliminated the financial barriers for this method. The growing number of scientific reports on the clinical benefits of TH increases the awareness of this method among Polish cardiologists. [8] [9] [10] [11] Positive results are more likely to be achieved if strict criteria for inclusion and exclusion are applied.
The primary aim of the survey was to determine the implementation of the ESC and ERS guidelines in the clinical practice of cardiology units.
Material and methods
The data was prospectively collected from June to December 2014, using telephone survey, fax, online and printed inquiry form (Supplement 1). The investigators made an attempt to contact each of the 150 CICUs located in Poland. The answers were obtained from members of the CICU medical team, in particular the head of the department or designated physician. In case there was no answer to the initial email/letter with the questionnaire, the center was contacted by phone. In total, up to 3 attempts were made to contact each center. A detailed questionnaire investigated the experience of the center with TH (questions 1-4), the local practice in place for the management of the patient (question 5), type of the mild TH protocol (questions 6-8 and 11-14), mode of cooling and temperature control (questions 9-10), obstacles related to the employment of TH in clinical practice (questions 15-16) and educational training received by the unit (questions 17-19). The investigators collected declarative data on the number of patients that were managed at each CICU and those successfully discharged from the hospital.
Descriptive statistics were used to present the results; the categorical data was presented as percentage and nominal numbers. The percentages were reported in reference to the number of centers that provided the answers unless clearly stated otherwise.
Results
Out of the 150 CICUs approached in the survey, approx. half provided answers to the questionnaire (53%, n = 79). Most centers replied to the questionnaire sent by traditional post (49%, 38), 36% (28) provided answer after telephone contact from the investigators, 16.5% (13) submitted their answers via email.
Twenty-four centers confirmed the active use of TH in CA patients, 63% of them declared using hypothermia in a pre-hospital setting ( Table 1 ). Almost half of the centers cooled less than 5 CA patients per year ( Fig. 1 ). All treating centers have a dedicated TH protocol in place; nearly all (96%, n = 23) used the target temperature range from 32 to 34°C. In most cases (58%, n = 14), the target temperature was maintained for 12-24 h, and in 38% it lasted for more than 24 h. The induction phase was usually performed using an intravenous infusion of cold fluids (96%, n = 23). External cooling methods were applied more often (75%, n = 18), usually without control equipment (42%, n = 10). Every 4 th center was equipped with an intravascular cooling system. The comparison of the main features of the TH protocols revealed that patients were qualified for the procedure regardless of the type of the 1 st cardiac rhythm (ventricular fibrillation, ventricular tachycardia, asystole or pulseless electrical activity).
Among the centers that do not perform TH, only 33% (n = 18) are considering using TH in the future as part of the local protocol for management of post CA patients. The main barrier for starting a TH program is lack of knowledge and experience (37%, n = 20). The centers were not aware that dedicated TH educational training is available (96%, n = 22) ( Table 2 ). Only 37% (n = 20) of the centers had participated as least once in a dedicated TH workshop on the risks and benefits related to the procedure (Table 3 ).
Discussion
The extended data surveillance conducted between June and December 2014 that included 150 CICUs in Poland revealed that 30.3% (24) of units use TH in their daily practice. This data is complimentary to the previously conducted survey among Polish ICUs, which revealed that 21.7% of the anesthesiology units surveyed have a TH program in place. 7 A direct comparison of this data with the present study has some clear limitations and should not be used to draw firm conclusions as the profile of the patients treated in ICUs and CICUs differs; there has been over 5 years' time difference, and meanwhile the reimbursement of TH has been introduced and there has been much more clinical evidence supporting temperature control in CA patients published recently. Still, the observed differences in the applied cooling methods show that over the years there was an increase in the usage of dedicated cooling devices with temperature feedback (7% in 2010 vs 20% in 2014). The use of temperature probes connected to the cooling device -a controlled feedback system -allows for continuous measurements of the patient's temperature and the adjustment of cooling elements accordingly. This approach is associated with increased safety and survival. 12, 13 ceived as a major problem, with only 7.7% of units indicating that it prevents them from running a TH program for comatose post-CA survivors. After the above-mentioned published randomized trial by Nielsen et al. that compared 2 target temperature strategies (33° vs 36°C), the view on the role of therapeutic hypothermia in post-resuscitation care has been extensively discussed. 15 The most recent "Guidelines for Resuscitation 2015" published by the European Resuscitation Council include an option to use the target temperature of 36°C instead of the previously recommended 32-34°C. As the present study describes experience before the year 2015, we have intentionally maintained the term TH. However, it should be underlined that in order to comply with the current evidence and guideline terminology, future methodology should implement the notion of target temperature management.
The major limitation of our study was a low response rate (53%) from CICUs. However, publication of the current results might in the future encourage other units to take part in a study and, more importantly, to start using TH in their wards. A direct comparison of anesthesiology units and cardiology units might be misleading as they differ in terms of patient profiles and indications for cooling. Nonetheless, one would expect that both types of units should have much higher rates of TH availability than is currently reported. The questionnaire used in the study had not been validated previously, therefore the results obtained should be interpreted causally. Nevertheless, we encourage authors of future studies to consider using this tool, which might provide additional date to validate it.
Conclusions
The use of TH in comatose patients after CA with ROSC is low. Scientific evidence supports the use of TH in this population to improve prognosis and quality of life. Financial restrictions have been eliminated recently, which could improve the adherence to the guidelines which recommend using TH in such patients. Therefore, a lack of knowledge and experience remain the greatest barriers for wide deployment of TH. There is an urgent need to expand education and training among cardiologists, provided by centers experienced in TH. The duration of active cooling in the present study was 12-24 h in 58.4% (14/24) of centers, 37.5% (9/24) of centers cooled for more than 24 h and only 4.2% (1/20) used TH for less than 12 h. Although the current recommendations support 24 h of active cooling, there is some weak evidence to extend this time to 36 h. 14 Likewise, the value of the target temperature is becoming a hot topic for discussion, given the recent results by Nielsen et al., who showed no benefit of 33° or 36°C. 15 We identified 1 cardiology center in Poland that conducts the target temperature management at 36°C.
The main barrier for not using TH by cardiologists in Poland is the lack of knowledge and experience, which is an obstacle for 37% of cardiology centers. Financial restrictions were raised by 17% of centers, which is comparable to that reported by other European countries, i.e., Austria and the Czech Republic. 16, 17 However, given that the reimbursement of therapeutic hypothermia is available to each and every CICU, and there are flexible modes for renting the TH equipment, this problem is probably more an issue of local awareness than actual financial constraints. In fact, access to the equipment is not per- 
